The company will not receive any of the proceeds from the shares sold by the selling securityholders.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SCLX:
- Scilex entered into a MOU for collaboration agreement with ACEA
- Scilex Holding Settles Lawsuit, Continues Litigation Against Ex-President
- Scilex Holding Explores Strategic Options for Semnur Pharmaceuticals
- Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, and Denali Capital Acquisition Corp. (Nasdaq: DECA) Enter into a Letter of Intent for a Proposed Business Combination
- Scilex’s Semnur Pharmaceuticals, Denali Capital enter business combination